adamantane has been researched along with Pancreatitis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Dicembrini, I; Mannucci, E; Monami, M; Montereggi, C; Nreu, B | 1 |
| Brea, J; Calvó-Tusell, C; Codony, S; Corpas, R; Feixas, F; Griñán-Ferré, C; Hammock, BD; Loza, MI; Morisseau, C; Osuna, S; Pallàs, M; Pérez, C; Pizarro-Delgado, J; Rodríguez-Franco, MI; Sanfeliu, C; Valverde, E; Vázquez, S; Vázquez-Carrera, M | 1 |
| Attila, T; Mungan, Z; Ünal Kabaoğlu, Z; Vural, M | 1 |
| Cohen, D | 1 |
| Bhatt, DL; Braunwald, E; Cavender, MA; Davidson, J; Desai, NR; Frederich, R; Hirshberg, B; Hoffman, EB; Leiter, LA; McGuire, DK; Mosenzon, O; Ohman, P; Ray, KK; Raz, I; Scirica, BM; Steg, PG; Udell, JA; Wiviott, SD | 1 |
| Bhatt, DL; Buskila, A; Greenberger, N; Hirshberg, B; Im, K; Iqbal, N; Lerch, MM; Mosenzon, O; Raz, I; Scirica, BM; Stahre, C; Umez-Eronini, A | 1 |
| Lee, CF; Sun, MS; Tai, YK | 1 |
| Athanasiadou, E; Bekiari, E; Boura, P; Karagiannis, T; Liakos, A; Mainou, M; Papatheodorou, K; Rika, M; Rizava, C; Tsapas, A | 1 |
| Raz, I; Tkáč, I | 1 |
| Busch, SJ; Foley, JE; Hoffmann, P; Johnson, R; Kothny, W; Meyer, F; Sahota, P | 1 |
| Higashi, Y; Inoue, G; Nakata, H; Ohtomo, Y; Otsu, S; Sugitani, S; Yamaji, S | 1 |
3 review(s) available for adamantane and Pancreatitis
| Article | Year |
|---|---|
Pancreatitis and pancreatic cancer in patientes treated with Dipeptidyl Peptidase-4 inhibitors: An extensive and updated meta-analysis of randomized controlled trials.
Topics: Adamantane; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Humans; Hypoglycemic Agents; Pancreatic Neoplasms; Pancreatitis; Randomized Controlled Trials as Topic; Sitagliptin Phosphate | 2020 |
Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes.
Topics: Adamantane; Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Metformin; Nitriles; Pancreatitis; Pyrrolidines; Treatment Outcome; Vildagliptin | 2016 |
Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes.
Topics: Acute Disease; Adamantane; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Humans; Incidence; Pancreatitis; Piperidines; Randomized Controlled Trials as Topic; Sitagliptin Phosphate; Uracil | 2017 |
2 trial(s) available for adamantane and Pancreatitis
| Article | Year |
|---|---|
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Topics: Adamantane; Aged; Aged, 80 and over; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatitis | 2013 |
Incidence of pancreatitis and pancreatic cancer in a randomized controlled multicenter trial (SAVOR-TIMI 53) of the dipeptidyl peptidase-4 inhibitor saxagliptin.
Topics: Adamantane; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; International Agencies; Male; Middle Aged; Pancreatic Neoplasms; Pancreatitis; Prognosis; Risk Factors | 2014 |
6 other study(ies) available for adamantane and Pancreatitis
| Article | Year |
|---|---|
From the Design to the
Topics: Acute Disease; Adamantane; Animals; Binding Sites; Catalytic Domain; Cell Membrane Permeability; Drug Design; Drug Stability; Enzyme Inhibitors; Epoxide Hydrolases; Half-Life; Humans; Hydrophobic and Hydrophilic Interactions; Male; Mice; Mice, Inbred C57BL; Molecular Dynamics Simulation; Pancreatitis; Rats; Structure-Activity Relationship | 2021 |
Vildagliptin-induced acute pancreatitis without enzyme elevation.
Topics: Abdominal Pain; Acute Disease; Adamantane; Aged; Amylases; Diabetes Mellitus, Type 2; Diagnosis, Differential; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Lipase; Male; Middle Aged; Nitriles; Pancreatitis; Pyrrolidines; Vildagliptin | 2017 |
Reports of pancreatitis are 20-30 times more likely with GLP-1 drugs, analysis finds.
Topics: Adamantane; Diabetes Mellitus; Dipeptides; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Linagliptin; Pancreatitis; Purines; Pyrazines; Quinazolines; Sitagliptin Phosphate; Triazoles; United States | 2013 |
Saxagliptin-induced recurrent acute pancreatitis.
Topics: Acute Disease; Adamantane; Aged, 80 and over; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Pancreatitis; Recurrence | 2014 |
Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in man.
Topics: Adamantane; Animals; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Islets of Langerhans; Male; Mice; Mice, Transgenic; Nitriles; Pancreas, Exocrine; Pancreatic Neoplasms; Pancreatitis; Predictive Value of Tests; Pyrrolidines; Rats; Rats, Transgenic; Rats, Wistar; Vildagliptin | 2013 |
Pancreatitis with pancreatic tail swelling associated with incretin-based therapies detected radiologically in two cases of diabetic patients with end-stage renal disease.
Topics: Adamantane; Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glucagon-Like Peptide 1; Humans; Incretins; Kidney Failure, Chronic; Liraglutide; Magnetic Resonance Imaging; Male; Nitriles; Pancreatitis; Pyrrolidines; Renal Dialysis; Tomography, X-Ray Computed; Vildagliptin | 2012 |